new indications for glp-1 drugs Market Overview: Agonists and the Obesity Market | Blog GLP-1 Medications for Weight Loss:

A research of 163 patients with idiopathic/hereditable pulmonary hypertension (PH), congenital heart disease-associated PH, and chronic thromboembolic PH examined plasma TMAO levels as a possible biomarker in PH

Mammalian lipoxygenases and their biological relevance

Neuroprotective mechanisms of glucagon-like peptide-1-based therapies in ischemic stroke: an update based on preclinical research

Topical BPC-157 formulations have shown effectiveness in research settings

Key takeaways Weight loss injections such as semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) work by mimicking a hormone that helps curb hunger and increase feelings of fullness after eating

doi: 10.1016/j.molmed.2023.05.013 48 BeauchampMCJerome-MajewskaLA